A comparison of the effectiveness and safety of insulin glargine 300 U/ml versus 100 U/ml in children and adolescents with newly diagnosed type 1 diabetes: A retrospective, observational, short-term study

Diabetes Obes Metab. 2022 Dec;24(12):2474-2477. doi: 10.1111/dom.14839. Epub 2022 Sep 5.
No abstract available

Publication types

  • Observational Study

MeSH terms

  • Adolescent
  • Blood Glucose
  • Child
  • Diabetes Mellitus, Type 1* / drug therapy
  • Glycated Hemoglobin / analysis
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Insulin Glargine / adverse effects
  • Insulin, Long-Acting / adverse effects
  • Retrospective Studies

Substances

  • Insulin Glargine
  • Insulin, Long-Acting
  • Hypoglycemic Agents
  • Glycated Hemoglobin A
  • Blood Glucose